Literature DB >> 8632728

Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin.

S Cos1, J Recio, E J Sánchez-Barceló.   

Abstract

It has been shown that melatonin has a direct inhibitory effect on the proliferation of MCF-7 human breast cancer cells in culture. In the present work, we studied whether the length of the cell cycle of MCF-7 cells in increased by melatonin. In MCF-7 cells partially synchronized and labelled with [3H]thymidine, melatonin (10(-9)M), added to the culture medium, shifted the period of the labeling index rhythm from 20.36 hours to 23.48 hours. The fact that melatonin significantly increased (p<0.005) the duration of the cell cycle of human breast cancer cells, support the notion that this hormone exerts part of its antitumor effect through a cell-cycle-specific mechanism by delaying the entry of MCF-7 cells into mitosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632728     DOI: 10.1016/0024-3205(95)02359-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Inhibitory effect of melatonin on the growth of H22 hepatocarcinoma cells by inducing apoptosis.

Authors:  Li Qin; Ximing Wang; Qiuhong Duan; Beibei Chen; Shanshu He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

2.  Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression.

Authors:  Thaiz Ferraz Borin; Ali Syed Arbab; Gabriela Bottaro Gelaleti; Lívia Carvalho Ferreira; Marina Gobbe Moschetta; Bruna Victorasso Jardim-Perassi; A S M Iskander; Nadimpalli Ravi S Varma; Adarsh Shankar; Verena Benedick Coimbra; Vanessa Alves Fabri; Juliana Garcia de Oliveira; Debora Aparecida Pires de Campos Zuccari
Journal:  J Pineal Res       Date:  2015-10-20       Impact factor: 13.007

Review 3.  Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review.

Authors:  Laura B Samuelsson; Dana H Bovbjerg; Kathryn A Roecklein; Martica H Hall
Journal:  Neurosci Biobehav Rev       Date:  2017-10-13       Impact factor: 8.989

4.  In silico simulation of the effect of hypoxia on MCF-7 cell cycle kinetics under fractionated radiotherapy.

Authors:  Adrian S Remigio
Journal:  J Biol Phys       Date:  2021-09-17       Impact factor: 1.560

Review 5.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

6.  Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways.

Authors:  Ran Liu; Alan Fu; Aaron E Hoffman; Tongzhang Zheng; Yong Zhu
Journal:  BMC Cell Biol       Date:  2013-01-07       Impact factor: 4.241

7.  Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.

Authors:  Angela Calastretti; Giuliana Gatti; Valeria Lucini; Silvana Dugnani; Gianfranco Canti; Francesco Scaglione; Annamaria Bevilacqua
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

8.  Competition and niche construction in a model of cancer metastasis.

Authors:  Jimmy J Qian; Erol Akçay
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

9.  The 1.5 GHz electromagnetic near-field used for cellular phones does not promote rat liver carcinogenesis in a medium-term liver bioassay.

Authors:  K Imaida; M Taki; S Watanabe; Y Kamimura; T Ito; T Yamaguchi; N Ito; T Shirai
Journal:  Jpn J Cancer Res       Date:  1998-10

Review 10.  Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers.

Authors:  Javier Menéndez-Menéndez; Carlos Martínez-Campa
Journal:  Int J Endocrinol       Date:  2018-10-02       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.